drugset / Trial / NCT03129542

Midodrine Hydrochloride in Early Sepsis

NCT03129542

Phase 1 Completed 33 enrolled Mayo Clinic Cleveland Clinic Abu Dhabi · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators would like to determine if early administration of oral Midodrine in participants diagnosed with sepsis will impact blood pressures and decrease the need for and/or doses of intravenous pressor agents.

Timeline

Start
2017-08-30
Primary completion
2020-04-28
Completion
2020-05-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midodrine Small molecule 10 mg Oral